688163 赛伦生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.1363.5138.61023.02920.010
总资产报酬率 ROA (%)0.1313.3798.18121.39318.656
投入资产回报率 ROIC (%)0.1333.4468.38722.21921.524

边际利润分析
销售毛利率 (%)71.46475.70983.77083.68283.532
营业利润率 (%)7.35824.18442.85542.26840.583
息税前利润/营业总收入 (%)5.33822.67240.96441.80339.241
净利润/营业总收入 (%)5.60720.39236.84936.64834.044

收益指标分析
经营活动净收益/利润总额(%)-106.68088.00678.66097.011109.020
价值变动净收益/利润总额(%)151.60322.75621.667-0.896-7.143
营业外收支净额/利润总额(%)-0.997-1.252-0.843-0.378-0.744

偿债能力分析
流动比率 (X)52.68637.97937.10414.05012.026
速动比率 (X)50.02836.18835.07511.2638.700
资产负债率 (%)3.1753.7783.8458.2565.620
带息债务/全部投入资本 (%)0.3070.3330.2940.712--
股东权益/带息债务 (%)31,975.54929,465.78033,387.04513,386.0629,068.029
股东权益/负债合计 (%)3,049.9532,547.0122,500.4961,111.2661,679.453
利息保障倍数 (X)-2.740-18.689-26.735-137.029-37.639

营运能力分析
应收账款周转天数 (天)104.59728.69717.84111.3920.000
存货周转天数 (天)552.715386.922660.221522.7440.000